Locus control regions: Overcoming heterochromatin-induced gene inactivation in mammals

Current Opinion in Genetics and Development

Volumn 7, Issue 5, 1997, Pages 614-619

  Kioussis, Dimitris ^a   Festenstein, Richard ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT;

CELL DIFFERENTIATION; DROSOPHILA; GENE REPRESSION; HETEROCHROMATIN; POSITION EFFECT; PRIORITY JOURNAL; REGULATOR GENE; SHORT SURVEY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; YEAST;

MAMMALIA; MUS MUSCULUS;

EID: 0030726908     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80008-1     Document Type: Article

References (57)

1. Grosveld F, Kollias G. Transgenic Animals. 1992;Academic Press, London.
2. Palmiter RD, Brinster RL. Germline transformation of mice. Annu Rev Genet. 20:1986;465-499.
3. Lewis EB. The phenomenon of position effect. Adv Genet. 3:1950;73-115.
4. Dobzhansky T. Position effects on genes. Biol Rev. 11:1936;364-434.
5. Sturtevant AH. The effects of unequal cross-over at the Barlocus in Drosophila. Genetics. 10:1925;117-147.
6. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell. 51:1987;975-985.
7. Kioussis D, Vanin E, de Lange T, Flavell RA, Grosveld FG. Betaglobin gene inactivation by DNA translocation in gamma betathalassaemia. Nature. 306:1983;662-666.
8. Van der Ploeg LH, Konings A, Oort M, Roos D, Bernini L, Flavell RA. Gamma-beta thalassaemia studies showing that deletion of the gamma- and delta-genes influences beta-globin gene expression in man. Nature. 283:1980;637-642.
9. Tuan D, Solomon W, Li Q, London IM. The 'beta-like-globin' gene domain in human erythroid cells. Proc Natl Acad Sci USA. 82:1985;6384-6388.
10. Forrester WC, Thompson C, Elder JT, Groudine MA. Developmentally stable chromatin structure in the human beta-globin gene-cluster. Proc Natl Acad Sci USA. 83:1986;1359-1363.
11. Greaves DR, Wilson F, Lang G, Kioussis D. Human CD2 3′- flanking sequences confer high-level T-cells specific position independent gene expression in transgenic mice. Cell. 56:1989;979.
12. Bonifer C, Vidal M, Grosveld F, Sippel AS. Tissue specific and position independent expression of complete gene domain for chicken lysozyme in transgenic mice. EMBO J. 9:1990;2843-2848.
13. Carson S, Wiles MW. Far upstream regions of class II MHC Ea are necessary for position-independent copy-dependent expression of Ea transgene. Nucleic Acids Res. 21:1993;2065-2072.
14. Dale TC, Krnacik MJ, Schmidhauser C, Yang CL, Bissell MJ, Rosen JM. High-level expression of the rat whey acidic protein gene is mediated by elements in the promoter and 3′ untranslated region. Mol Cell Biol. 12:1992;905-914.
15. Diaz P, Cado D, Winoto AA. Locus control region in the T cell receptor alpha/delta locus. Immunity. 1:1994;207-217.
16. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol. 13:1993;5266-5275.
17. Reitman M, Lee E, Westphal H, Felsenfeld G. Site-independent expression of the chicken beta A-globin gene in transgenic mice. Nature. 348:1990;749-752.
18. Schedl A, Montoliu L, Kelsey G, Schutz A. A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature. 362:1993;258-261.
19. Strauss WM, Dausman J, Beard C, Johnson C, Lawrence JB, Jaenisch R. Germ line transmission of a yeast artificial chromosome spanning the murine alpha 1(I) collagen locus. Science. 259:1993;1904-1907.
20. Talbot D, Descombes P, Schibler U. The 5′ flanking region of the rat LAP (C/EBP beta) gene can direct high-level, position-independent, copy number-dependent expression in multiple tissues in transgenic mice. Nucleic Acids Res. 1994;756-766.
21. Aronow BJ, Ebert CA, Valerius MT, Potter SS, Wiginton DA, Witte DP, Hutton JJ. Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences. Mol Cell Biol. 15:1995;1123-1135.
22. Jenuwein T, Forrester WC, Fernandez Herrero LA, Laible G, Dull M, Grosschedl R. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature. 385:1997;269-272.
23. Dillon N, Grosveld F. Transcriptional regulation of multigene loci: multilevel control. Trends Genet. 9:1993;134-137.
24. Dillon N, Grosveld F. Chromatin domains as potential units of eukaryotic gene function. Curr Opin Genet Dev. 4:1994;260-264.
25. Pruzina S, Hanscombe O, Whyatt D, Grosveld F, Philipsen S. Hypersensitive site 4 of the human Beta-globin locus control region. Nucleic Acids Res. 19:1991;1413-1419.
26. Talbot D, Philipsen S, Fraser P, Grosveld F. Detailed analysis of the site 3 region of the human Beta-globin dominant control region. EMBO J. 9:1990;2169-2178.
27. Talbot D, Grosveld F. The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J. 10:1991;1391-1398.
28. Philipsen S, Talbot D, Fraser P, Grosveld F. The Beta-globin dominant control region: hypersensitive site 2. EMBO J. 9:1990;2159-2167.
29. Ellis J, Tan Un JC, Harper A, Michalovich D, Yannoutsos N, Philipsen S, Grosveld F. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human beta-globin locus control region. EMBO J. 15:1996;562-568.
30. Lake RA, Wotton D, Owen MJ. A 3′ transcriptional enhancer regulates tissue-specific expression of the human CD2 gene. EMBO J. 9:1990;3129-3136.
31. Festenstein R, Tolaini M, Corbella P, Mamalaki C, Parrington J, Fox M, Miliou A, Jones M, Kioussis D. Locus control region function and heterochromatin-induced position effect variegation. of outstanding interest Science. 271:1996;1123-1125 A series of LCR deletions linked to the human CD2 gene and assayed in transgenic mouse lines established that this LCR can overcome centromere-induced PEV in mammalian system. These experiments allowed the separation of hCD2+ and hCD2- cells from individual transgenic thymuses. It was subsequently shown, using DNAse 1 accessibility studies, that the transgene in the hCD2- cells was in a closed chromatin configuration. These studies have provided the most direct evidence that LCR function and PEV are mediated at the chromatin level.
32. Karpen GH. Position-effect variegation and the new biology of heterochromatin. Curr Opin Genet Dev. 4:1994;281-291.
33. Singh PB, Miller JR, Pearce J, Kothary R, Burton RD, Paro R, James TC, Gaunt SJ. A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants. Nucleic Acids Res. 19:1991;789-794.
34. Allshire RC, Javerzat J-P, Redhead NJ, Cranston G. Position effect variegation at fission yeast centromeres. Cell. 76:1994;157-169.
35. Walters MC, Fiering S, Eidemiller J, Magis W, Groudine M, Martin DIK. Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci USA. 92:1995;7125-7129.
36. Boyes J, Felsenfeld G. Tissue-specific factors additively increase the probability of the all-or-none formation of a hypersensitive site. of special interest EMBO J. 15:1996;2496-2507 Restriction enzyme accessibility was used as an assay for chromatin structure in a cellular assay to demonstrate that there was 'variegation' in the setting up of a DNAse I hypersensitive site in vitro. This was consistent with the important observation that enhancers increase the probability of setting up an active transcriptional unit rather than increasing the level of transcription of a single template [35].
37. Milot E, Strouboulis J, Trimborn T, Wijgerde M, de Boer E, Langeveld A, Tan-Un K, Vergreer W, Yannoutsos N, Grosveld F. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. of outstanding interest Cell. 87:1996;105-114 As well as showing that centromeric PEV can occur in transgenic mice with human β-globin LCR deletions, the authors also identified a new type of 'timing'-dependent position effect (see text). Taken together with the findings in [31], these results strongly indicate a high level of conservation of these phenomena in divergent eukaryotes.
38. Robertson G, Garrick D, Wu W, Kearns M, Martin D, Whitelaw E. Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci USA. 92:1995;5371-5375.
39. Pravtcheva DD, Wise TL, Ensor NJ, Ruddle FH. Mosaic expression of an Hprt transgene integrated in a region of Y heterochromatin. J Exp Zool. 268:1994;452-468.
40. Guy LG, Kothary R, De Repentigny Y, Delvoye N, Ellis J, Wall L. The beta-globin locus control region enhances transcription of but does not confer position-independent expression onto the lacZ gene in transgenic mice. EMBO J. 15:1996;3713-3721.
41. Dobie KW, Lee M, Fanters JA, Graham E, Clark AJ, Springbett A, Lathe R, McClenaghan M. Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus. of special interest Proc Natl Acad Sci USA. 93:1996;6659-6664 This paper was one of the first to show PEV to be associated with pericentromeric locations by using mice transgenic for the β-lactoglobulin gene.
42. Kellun R, Schedl P. A position-effect assay for boundaries of higher order chromosomal domains. Cell. 64:1991;941-950.
43. Roseman RR, Pirrotta V, Geyer PK. The su(Hw) protein insulates expression of the Drosophila melanogaster white gene from chromosomal position-effects. EMBO J. 12:1993;435-442.
44. Chung JH, Whiteley M, Felsenfeld G. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell. 74:1993;505-514.
45. Li Q, Stamatoyannopoulos G. Hypersensitive site 5 of the human beta locus control region functions as a chromatin insulator. Blood. 84:1994;1399-1401.
46. Locke J, Kotarski MA, Tartof KD. Dosage-dependent modifiers of positional effect variegation in Drosophila and a mass action model that explains their effect. Genetics. 120:1988;181-198.
47. Henikoff S. Dosage-dependent modification of position-effect variegation in Drosophila. Bioessays. 18:1996;401-409.
48. Eissenberg JC, Morris GD, Reuter G, Hartnett T. The heterochromatin-associated protein HP-1 is an essential protein in Drosophila with dosage-dependent effects on position-effect variegation. Genetics. 131:1992;345-352.
49. Eissenberg JC, James TC, Foster-Hartnett DM, Hartnett T, Ngan V, Elgin SC. Mutation in a heterochromatin-specific chromosomal protein is associated with suppression of position-effect variegation in Drosophila melanogaster. Proc Natl Acad Sci USA. 87:1990;9923-9927.
50. Aparicio OM, Gottschling DE. Overcoming telomeric silencing: a trans-activator competes to establish gene expression in a cell cycle-dependent way. Genes Dev. 8:1994;1133-1146.
51. Singh PB. Molecular mechanisms of cellular determination: their relation to chromatin structure. J Cell Sci. 107:1994;2653-2668.
52. Singh PB, Brown D. Modelling the activity of the ultrabithorax parasegment-specific regulatory domains around their anterior boundaries. J Theor Biol. 186:1997;387-413.
53. Kioussis D, Festenstein R. Chromatin structure and lineage commitment and T lymphopoeisis. Monroe JG, Rothenberg E, Totowa NJ. The Molecular Biology of B and T Cell Development. 1997;Humana Press.
54. Elliott J, Festenstein R, Tolaini M, Kioussis D. Random activation of a transgene under the control of a hybrid hCD2 locus control region/lg enhancer regulatory element. EMBO. 14:1995;575-584.
55. Gottshling DE, Aparicio OM, Billington BL, Zakian VA. Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription. Cell. 63:1990;751-762.
56. Wijgerde M, Grosveld F, Fraser P. Transcription complex stability and chromatin dynamics in vivo. Nature. 377:1995;209-213.
57. Green JB, Smith JC. Graded changes in dose of an activin A homologue elicit stepwise transitions in Xenopus embryonic cell fate [see comments]. Nature. 347:1990;391-394.